How to Buy thyrocare Shares on Fincept?
You can buy Thyrocare Technologies Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Thyrocare Technologies Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Thyrocare, including updates on board meetings and corporate actions.
Thyrocare Technologies Limited - https://www.thyrocare.com
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Thyrocare Technologies Limited Share Price Today
786.75
OPEN
788.55
HIGH
770.15
LOW
777.15
CLOSE
75 K
VOLUME
4,992 Cr
Market Cap
81250
Average Volume
Healthcare
Sector
NSI
Exchange
Thyrocare Technologies Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: THYROCARE Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Thyrocare Technologies Limited |
THYROCARE |
INE594H01019 |
Dividend - Rs 18 Per Share |
16 Aug 2024 |
10 |
N/A |
Thyrocare Technologies Limited |
THYROCARE |
INE594H01019 |
Interim Dividend - Rs 18 Per Share |
20 Apr 2023 |
10 |
N/A |
Thyrocare Technologies Limited |
THYROCARE |
INE594H01019 |
Annual General Meeting |
25 Jul 2022 |
10 |
N/A |
Thyrocare Technologies Limited |
THYROCARE |
INE594H01019 |
Interim Dividend - Rs 15 Per Share |
11 May 2022 |
10 |
N/A |
Thyrocare Technologies Limited |
THYROCARE |
INE594H01019 |
Annual General Meeting/Dividend - Rs 15 Per Share |
17 Jun 2021 |
10 |
N/A |
NSE: THYROCARE Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
THYROCARE |
01 Jan 2025, 11:28:29 |
Updates |
N/A |
THYROCARE |
24 Dec 2024, 15:45:13 |
Trading Window-XBRL |
N/A |
THYROCARE |
24 Dec 2024, 15:34:53 |
Trading Window |
N/A |
THYROCARE |
10 Dec 2024, 17:19:40 |
Alteration Of Capital and Fund Raising-XBRL |
N/A |
THYROCARE |
10 Dec 2024, 16:32:29 |
ESOP/ESOS/ESPS |
N/A |
NSE: THYROCARE Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Thyrocare Technologies Limited |
THYROCARE |
19 Oct 2024, 21:12:00 |
19 Oct 2024, 21:12:00 |
|
Thyrocare Technologies Limited |
THYROCARE |
29 Aug 2024, 10:02:00 |
29 Aug 2024, 10:02:00 |
|
Thyrocare Technologies Limited |
THYROCARE |
17 Apr 2024, 18:42:00 |
17 Apr 2024, 19:00:00 |
|
Thyrocare Technologies Limited |
THYROCARE |
16 Jan 2024, 16:45:00 |
16 Jan 2024, 17:15:00 |
|
Thyrocare Technologies Limited |
THYROCARE |
20 Oct 2023, 19:45:00 |
20 Oct 2023, 20:15:00 |
NSE: THYROCARE Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director-CEO-MD |
02 Mar 1978 |
04 May 2022 |
09588432 |
Rahul Guha |
Active |
Non-Executive Director |
19 Sep 1988 |
02 Sep 2021 |
06999772 |
Dharmil Nirupam Sheth |
Active |
Non-Executive Director |
17 Feb 1989 |
02 Sep 2021 |
06660799 |
Hardik Kishor Dedhia |
Active |
Non-Executive Director |
18 Oct 1988 |
06 Oct 2021 |
07485688 |
Dhaval Rajesh Shah |
Active |
Independent Director |
16 Jun 1959 |
21 Aug 2014 |
00157676 |
Gopalkrishna Shivaram Hegde |
Active |
NSE: THYROCARE Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
THYROCARE |
N/A |
INE594H01019 |
Thyrocare Technologies Limited |
16 Oct 2024, 18:19:55 |
THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 23-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
THYROCARE |
N/A |
INE594H01019 |
Thyrocare Technologies Limited |
18 Jul 2024, 15:14:05 |
Financial Results/Dividend |
THYROCARE |
N/A |
INE594H01019 |
Thyrocare Technologies Limited |
07 May 2024, 16:34:32 |
THYROCARE TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 01-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
THYROCARE |
N/A |
INE594H01019 |
Thyrocare Technologies Limited |
24 Jan 2024, 20:47:03 |
Financial Results |
THYROCARE |
N/A |
INE594H01019 |
Thyrocare Technologies Limited |
23 Oct 2023, 18:57:02 |
NSE: THYROCARE Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
THYROCARE |
- |
INE594H01019 |
Thyrocare Technologies Limited |
16 Oct 2024, 00:00:00 |
To consider and approve the financial results for the quarter and half year ended September 30, 2024 |
Financial Results |
THYROCARE |
- |
INE594H01019 |
Thyrocare Technologies Limited |
17 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
THYROCARE |
- |
INE594H01019 |
Thyrocare Technologies Limited |
07 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and recommendation of final dividend, if any |
Financial Results |
THYROCARE |
- |
INE594H01019 |
Thyrocare Technologies Limited |
24 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
Financial Results |
THYROCARE |
- |
INE594H01019 |
Thyrocare Technologies Limited |
23 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 |
NSE: THYROCARE Balance Sheet Data In (Cr)
| date | period_type | Treasury Shares Number | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Long Term Equity Investment | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Raw Materials | Other Receivables | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 0.00 | 52,952,312.00 | 52,952,312.00 | 0.00 | 185,500,000.00 | 3,801,400,000.00 | 4,882,800,000.00 | 1,500,000,000.00 | 3,801,400,000.00 | 184,300,000.00 | 4,881,600,000.00 | 4,881,600,000.00 | 4,886,700,000.00 | 5,100,000.00 | 4,881,600,000.00 | 4,352,100,000.00 | 0.00 | 0.00 | 529,500,000.00 | 529,500,000.00 | 1,084,100,000.00 | 135,700,000.00 | -100,000.00 | 0.00 | 0.00 | 99,600,000.00 | 99,600,000.00 | 0.00 | 36,200,000.00 | 948,400,000.00 | 29,900,000.00 | 0.00 | 85,900,000.00 | 84,700,000.00 | 1,200,000.00 | 0.00 | 40,000,000.00 | 509,600,000.00 | 0.00 | 0.00 | 52,400,000.00 | 457,200,000.00 | 5,970,800,000.00 | 3,522,500,000.00 | 15,400,000.00 | 0.00 | 173,400,000.00 | 63,700,000.00 | 63,700,000.00 | 249,700,000.00 | 0.00 | 1,080,200,000.00 | 27,700,000.00 | 1,052,500,000.00 | 1,872,600,000.00 | 0.00 | 1,872,600,000.00 | 6,000,000.00 | 1,866,600,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,448,400,000.00 | 127,800,000.00 | 0.00 | 0.00 | 0.00 | 440,700,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 479,300,000.00 | 0.00 | 0.00 | 1,400,600,000.00 | 943,300,000.00 | 457,300,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 364.00 | 52,952,312.00 | 52,952,676.00 | 123,000,000.00 | 423,400,000.00 | 4,220,500,000.00 | 5,483,700,000.00 | 1,880,300,000.00 | 4,220,500,000.00 | 207,400,000.00 | 5,267,700,000.00 | 5,376,800,000.00 | 5,276,300,000.00 | 8,600,000.00 | 5,267,700,000.00 | 385,300,000.00 | 3,191,900,000.00 | 752,200,000.00 | 529,500,000.00 | 529,500,000.00 | 1,162,500,000.00 | 257,700,000.00 | -4,300,000.00 | 30,600,000.00 | 0.00 | 227,100,000.00 | 118,000,000.00 | 109,100,000.00 | 30,600,000.00 | 904,800,000.00 | 5,000,000.00 | 12,900,000.00 | 196,300,000.00 | 89,400,000.00 | 106,900,000.00 | 0.00 | 28,100,000.00 | 445,900,000.00 | 44,700,000.00 | 100,000.00 | 12,900,000.00 | 401,100,000.00 | 6,438,800,000.00 | 3,653,700,000.00 | 100,000.00 | 162,900,000.00 | 148,200,000.00 | 52,200,000.00 | 52,200,000.00 | 256,200,000.00 | 256,200,000.00 | 1,047,200,000.00 | 6,900,000.00 | 1,040,300,000.00 | 2,037,000,000.00 | -1,924,500,000.00 | 3,961,500,000.00 | 25,500,000.00 | 2,011,600,000.00 | 2,975,500,000.00 | 643,300,000.00 | 317,200,000.00 | 0.00 | 2,785,100,000.00 | 75,600,000.00 | 0.00 | 305,300,000.00 | 101,900,000.00 | 475,200,000.00 | 0.00 | 31,300,000.00 | 443,900,000.00 | 6,900,000.00 | 434,700,000.00 | -228,000,000.00 | 662,700,000.00 | 1,461,100,000.00 | 1,368,100,000.00 | 93,000,000.00 | 0.00 | 93,000,000.00 |
| 2024-03-31T00:00:00 | annual | 364.00 | 52,952,312.00 | 52,952,676.00 | 123,000,000.00 | 423,400,000.00 | 4,220,500,000.00 | 5,483,700,000.00 | 1,880,300,000.00 | 4,220,500,000.00 | 207,400,000.00 | 5,267,700,000.00 | 5,376,800,000.00 | 5,276,300,000.00 | 8,600,000.00 | 5,267,700,000.00 | 385,300,000.00 | 3,191,900,000.00 | 752,200,000.00 | 529,500,000.00 | 529,500,000.00 | 1,162,500,000.00 | 257,700,000.00 | -4,300,000.00 | 30,600,000.00 | 0.00 | 227,100,000.00 | 118,000,000.00 | 109,100,000.00 | 30,600,000.00 | 904,800,000.00 | 5,000,000.00 | 12,900,000.00 | 196,300,000.00 | 89,400,000.00 | 106,900,000.00 | 0.00 | 28,100,000.00 | 445,900,000.00 | 44,700,000.00 | 100,000.00 | 12,900,000.00 | 401,100,000.00 | 6,438,800,000.00 | 3,653,700,000.00 | 100,000.00 | 162,900,000.00 | 148,200,000.00 | 52,200,000.00 | 52,200,000.00 | 256,200,000.00 | 256,200,000.00 | 1,047,200,000.00 | 6,900,000.00 | 1,040,300,000.00 | 2,037,000,000.00 | -1,924,500,000.00 | 3,961,500,000.00 | 25,500,000.00 | 2,011,600,000.00 | 2,975,500,000.00 | 643,300,000.00 | 317,200,000.00 | 0.00 | 2,785,100,000.00 | 75,600,000.00 | 0.00 | 305,300,000.00 | 101,900,000.00 | 475,200,000.00 | 0.00 | 31,300,000.00 | 443,900,000.00 | 6,900,000.00 | 434,700,000.00 | -228,000,000.00 | 662,700,000.00 | 1,461,100,000.00 | 1,368,100,000.00 | 93,000,000.00 | 0.00 | 93,000,000.00 |
| 2023-09-30T00:00:00 | quarterly | 364.00 | 52,929,679.00 | 52,930,043.00 | 92,400,000.00 | 470,200,000.00 | 3,849,700,000.00 | 5,101,600,000.00 | 1,404,300,000.00 | 3,849,700,000.00 | 231,100,000.00 | 4,862,500,000.00 | 5,016,600,000.00 | 4,876,400,000.00 | 13,900,000.00 | 4,862,500,000.00 | 4,333,200,000.00 | 0.00 | 0.00 | 529,300,000.00 | 529,300,000.00 | 1,050,500,000.00 | 364,200,000.00 | 0.00 | 0.00 | 0.00 | 307,500,000.00 | 153,400,000.00 | 154,100,000.00 | 56,700,000.00 | 686,300,000.00 | 85,300,000.00 | 0.00 | 162,700,000.00 | 77,700,000.00 | 85,000,000.00 | 0.00 | 9,400,000.00 | 278,500,000.00 | 0.00 | 0.00 | 100,400,000.00 | 178,100,000.00 | 5,926,900,000.00 | 3,836,300,000.00 | 248,900,000.00 | 0.00 | 133,000,000.00 | 289,900,000.00 | 289,900,000.00 | 0.00 | 0.00 | 1,012,800,000.00 | 10,000,000.00 | 1,002,800,000.00 | 1,934,800,000.00 | 0.00 | 1,934,800,000.00 | 28,300,000.00 | 1,906,500,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,090,600,000.00 | 159,400,000.00 | 0.00 | 0.00 | 0.00 | 322,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 553,600,000.00 | 0.00 | 0.00 | 1,054,800,000.00 | 908,100,000.00 | 146,700,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 364.00 | 52,929,679.00 | 52,930,043.00 | 0.00 | 233,100,000.00 | 4,332,300,000.00 | 5,343,000,000.00 | 1,958,400,000.00 | 4,332,300,000.00 | 233,100,000.00 | 5,343,000,000.00 | 5,343,000,000.00 | 5,352,200,000.00 | 9,200,000.00 | 5,343,000,000.00 | 234,500,000.00 | 3,434,200,000.00 | 736,200,000.00 | 529,300,000.00 | 529,300,000.00 | 975,000,000.00 | 204,000,000.00 | 0.00 | 33,000,000.00 | 9,800,000.00 | 161,200,000.00 | 161,200,000.00 | 0.00 | 33,000,000.00 | 771,000,000.00 | 79,100,000.00 | 100,400,000.00 | 71,900,000.00 | 71,900,000.00 | 0.00 | 0.00 | 40,400,000.00 | 341,700,000.00 | 100,200,000.00 | 1,600,000.00 | 18,300,000.00 | 239,900,000.00 | 6,327,200,000.00 | 3,597,800,000.00 | 50,700,000.00 | 297,000,000.00 | 122,700,000.00 | 62,900,000.00 | 62,900,000.00 | 221,000,000.00 | 221,000,000.00 | 1,010,700,000.00 | 7,900,000.00 | 1,002,800,000.00 | 1,944,300,000.00 | -1,650,200,000.00 | 3,594,500,000.00 | 16,100,000.00 | 1,928,200,000.00 | 2,627,200,000.00 | 634,800,000.00 | 316,400,000.00 | 0.00 | 2,729,400,000.00 | 53,200,000.00 | 0.00 | 107,000,000.00 | 88,300,000.00 | 276,700,000.00 | 0.00 | 16,400,000.00 | 260,300,000.00 | 5,500,000.00 | 851,200,000.00 | -214,100,000.00 | 1,065,300,000.00 | 1,400,700,000.00 | 1,223,000,000.00 | 177,700,000.00 | 0.00 | 177,700,000.00 |
| 2023-03-31T00:00:00 | annual | 364.00 | 52,929,679.00 | 52,930,043.00 | 0.00 | 233,100,000.00 | 4,332,300,000.00 | 5,343,000,000.00 | 1,958,400,000.00 | 4,332,300,000.00 | 233,100,000.00 | 5,343,000,000.00 | 5,343,000,000.00 | 5,352,200,000.00 | 9,200,000.00 | 5,343,000,000.00 | 234,500,000.00 | 3,434,200,000.00 | 736,200,000.00 | 529,300,000.00 | 529,300,000.00 | 975,000,000.00 | 204,000,000.00 | 0.00 | 33,000,000.00 | 9,800,000.00 | 161,200,000.00 | 161,200,000.00 | 0.00 | 33,000,000.00 | 771,000,000.00 | 79,100,000.00 | 100,400,000.00 | 71,900,000.00 | 71,900,000.00 | 0.00 | 0.00 | 40,400,000.00 | 341,700,000.00 | 100,200,000.00 | 1,600,000.00 | 18,300,000.00 | 239,900,000.00 | 6,327,200,000.00 | 3,597,800,000.00 | 50,700,000.00 | 297,000,000.00 | 122,700,000.00 | 62,900,000.00 | 62,900,000.00 | 221,000,000.00 | 221,000,000.00 | 1,010,700,000.00 | 7,900,000.00 | 1,002,800,000.00 | 1,944,300,000.00 | -1,650,200,000.00 | 3,594,500,000.00 | 16,100,000.00 | 1,928,200,000.00 | 2,627,200,000.00 | 634,800,000.00 | 316,400,000.00 | 0.00 | 2,729,400,000.00 | 53,200,000.00 | 0.00 | 107,000,000.00 | 88,300,000.00 | 276,700,000.00 | 0.00 | 16,400,000.00 | 260,300,000.00 | 5,500,000.00 | 851,200,000.00 | -214,100,000.00 | 1,065,300,000.00 | 1,400,700,000.00 | 1,223,000,000.00 | 177,700,000.00 | 0.00 | 177,700,000.00 |
| 2022-03-31T00:00:00 | annual | 364.00 | 52,902,968.00 | 52,903,332.00 | 0.00 | 207,000,000.00 | 4,254,600,000.00 | 5,265,700,000.00 | 2,055,000,000.00 | 4,254,600,000.00 | 207,000,000.00 | 5,265,700,000.00 | 5,265,700,000.00 | 5,265,700,000.00 | 0.00 | 5,265,700,000.00 | 34,400,000.00 | 3,568,800,000.00 | 724,700,000.00 | 529,000,000.00 | 529,000,000.00 | 810,900,000.00 | 165,700,000.00 | 0.00 | 2,700,000.00 | 6,000,000.00 | 157,000,000.00 | 157,000,000.00 | 0.00 | 2,700,000.00 | 645,200,000.00 | 111,700,000.00 | 14,400,000.00 | 50,000,000.00 | 50,000,000.00 | 0.00 | 0.00 | 66,900,000.00 | 253,100,000.00 | 77,600,000.00 | 10,200,000.00 | 18,300,000.00 | 165,300,000.00 | 6,076,600,000.00 | 3,376,400,000.00 | 34,000,000.00 | 188,700,000.00 | 64,900,000.00 | 90,500,000.00 | 90,500,000.00 | 209,200,000.00 | 209,200,000.00 | 1,011,100,000.00 | 8,300,000.00 | 1,002,800,000.00 | 1,867,900,000.00 | -1,357,300,000.00 | 3,225,200,000.00 | 29,500,000.00 | 1,838,400,000.00 | 2,296,100,000.00 | 572,700,000.00 | 326,900,000.00 | 0.00 | 2,700,200,000.00 | 112,800,000.00 | 0.00 | 2,800,000.00 | 119,500,000.00 | 245,300,000.00 | 0.00 | 12,200,000.00 | 233,100,000.00 | 12,200,000.00 | 932,000,000.00 | -119,000,000.00 | 1,051,000,000.00 | 1,388,400,000.00 | 1,252,100,000.00 | 136,300,000.00 | 0.00 | 136,300,000.00 |
| 2021-03-31T00:00:00 | annual | 0.00 | 52,874,419.00 | 52,874,419.00 | 0.00 | 84,900,000.00 | 3,260,300,000.00 | 4,272,800,000.00 | 1,453,400,000.00 | 3,260,300,000.00 | 84,900,000.00 | 4,272,800,000.00 | 4,272,800,000.00 | 4,272,800,000.00 | 0.00 | 4,272,800,000.00 | 29,400,000.00 | 2,599,200,000.00 | 706,700,000.00 | 528,700,000.00 | 528,700,000.00 | 1,185,200,000.00 | 234,200,000.00 | 43,900,000.00 | 135,800,000.00 | 43,900,000.00 | 54,500,000.00 | 54,500,000.00 | 0.00 | 135,800,000.00 | 951,000,000.00 | 272,000,000.00 | 25,700,000.00 | 30,400,000.00 | 30,400,000.00 | 0.00 | 68,900,000.00 | 33,900,000.00 | 400,200,000.00 | 148,900,000.00 | 1,200,000.00 | 18,600,000.00 | 250,100,000.00 | 5,458,000,000.00 | 3,053,600,000.00 | 100,000.00 | 142,100,000.00 | 56,300,000.00 | 30,800,000.00 | 30,800,000.00 | 211,000,000.00 | 211,000,000.00 | 1,012,500,000.00 | 9,700,000.00 | 1,002,800,000.00 | 1,600,900,000.00 | -1,111,000,000.00 | 2,711,900,000.00 | 82,800,000.00 | 1,518,000,000.00 | 1,823,200,000.00 | 578,000,000.00 | 227,900,000.00 | 0.00 | 2,404,400,000.00 | 28,400,000.00 | 403,500,000.00 | 25,300,000.00 | 57,600,000.00 | 233,600,000.00 | 0.00 | 1,000,000.00 | 232,600,000.00 | 60,700,000.00 | 446,800,000.00 | -26,600,000.00 | 473,400,000.00 | 1,176,900,000.00 | 1,044,900,000.00 | 132,000,000.00 | 0.00 | 132,000,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,500,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 25,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54,100,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 311,400,000.00 | 0.00 | 0.00 | 0.00 | 3,800,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23,600,000.00 | 0.00 |
NSE: THYROCARE Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repurchase Of Capital Stock | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Payments | Common Stock Issuance | Net Issuance Payments Of Debt | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Business Purchase And Sale | Sale Of Business | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1,060,500,000.00 | 0.00 | -70,300,000.00 | 286,200,000.00 | 200,000.00 | -615,800,000.00 | 93,000,000.00 | -100,000.00 | 177,700,000.00 | -84,600,000.00 | -848,100,000.00 | 12,100,000.00 | -66,400,000.00 | -952,700,000.00 | -952,700,000.00 | 200,000.00 | 0.00 | 200,000.00 | 215,900,000.00 | 215,900,000.00 | -70,300,000.00 | 286,200,000.00 | -912,800,000.00 | 0.00 | 9,800,000.00 | 0.00 | -278,800,000.00 | 0.00 | -314,000,000.00 | -35,200,000.00 | 0.00 | -35,200,000.00 | -608,600,000.00 | 7,200,000.00 | -615,800,000.00 | 1,676,300,000.00 | -289,900,000.00 | 301,600,000.00 | 3,800,000.00 | 21,600,000.00 | 161,200,000.00 | -198,500,000.00 | 328,200,000.00 | 32,200,000.00 | 166,700,000.00 | 88,300,000.00 | 470,100,000.00 | 0.00 | 470,100,000.00 | 0.00 | -57,900,000.00 | 0.00 | 9,300,000.00 | 0.00 | 955,900,000.00 |
| 2023-03-31T00:00:00 | annual | 856,600,000.00 | -55,300,000.00 | 0.00 | 0.00 | 300,000.00 | -436,500,000.00 | 177,700,000.00 | 0.00 | 136,300,000.00 | 41,400,000.00 | -861,800,000.00 | 9,200,000.00 | -22,500,000.00 | -793,500,000.00 | -793,500,000.00 | 300,000.00 | -55,300,000.00 | 300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -389,900,000.00 | 1,300,000.00 | 13,000,000.00 | 0.00 | 12,600,000.00 | 1,932,500,000.00 | -1,919,900,000.00 | 0.00 | 0.00 | 0.00 | -415,500,000.00 | 21,000,000.00 | -436,500,000.00 | 1,293,100,000.00 | -284,600,000.00 | 57,900,000.00 | -27,300,000.00 | 51,800,000.00 | 74,200,000.00 | -31,400,000.00 | -13,700,000.00 | 9,700,000.00 | 211,700,000.00 | 95,200,000.00 | 387,100,000.00 | 8,400,000.00 | 378,700,000.00 | 0.00 | -53,700,000.00 | 0.00 | -4,300,000.00 | 0.00 | 874,100,000.00 |
| 2022-03-31T00:00:00 | annual | 755,800,000.00 | -53,800,000.00 | 0.00 | 0.00 | 300,000.00 | -378,300,000.00 | 136,300,000.00 | 0.00 | 132,000,000.00 | 4,300,000.00 | -894,100,000.00 | 0.00 | -47,500,000.00 | -793,100,000.00 | -793,100,000.00 | 300,000.00 | -53,800,000.00 | 300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -235,700,000.00 | 0.00 | 7,300,000.00 | 0.00 | -136,500,000.00 | 1,593,500,000.00 | -1,730,000,000.00 | 42,500,000.00 | 42,500,000.00 | 0.00 | -149,000,000.00 | 229,300,000.00 | -378,300,000.00 | 1,134,100,000.00 | -567,600,000.00 | -792,200,000.00 | 67,100,000.00 | -75,100,000.00 | -84,800,000.00 | -11,700,000.00 | -587,600,000.00 | 16,600,000.00 | 23,200,000.00 | 102,000,000.00 | 338,700,000.00 | 0.00 | 338,700,000.00 | 0.00 | -52,200,000.00 | 0.00 | -193,900,000.00 | -19,500,000.00 | 2,279,000,000.00 |
| 2021-03-31T00:00:00 | annual | 880,400,000.00 | 0.00 | -25,000,000.00 | 0.00 | 300,000.00 | -266,900,000.00 | 132,000,000.00 | 100,000.00 | 87,100,000.00 | 44,900,000.00 | -615,800,000.00 | -100,000.00 | -6,900,000.00 | -528,400,000.00 | -528,400,000.00 | 300,000.00 | 0.00 | 300,000.00 | -25,000,000.00 | -25,000,000.00 | -25,000,000.00 | 0.00 | -486,600,000.00 | 0.00 | 3,700,000.00 | 0.00 | -319,000,000.00 | 1,042,100,000.00 | -1,361,100,000.00 | 42,500,000.00 | 42,500,000.00 | 0.00 | -213,800,000.00 | 53,100,000.00 | -266,900,000.00 | 1,147,300,000.00 | -432,100,000.00 | -176,500,000.00 | 71,700,000.00 | -41,400,000.00 | 31,500,000.00 | -27,400,000.00 | -270,200,000.00 | 1,000,000.00 | 16,800,000.00 | 4,300,000.00 | 302,800,000.00 | 0.00 | 302,800,000.00 | 16,800,000.00 | -36,800,000.00 | 0.00 | -42,000,000.00 | -16,400,000.00 | 1,525,400,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -270,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,400,000.00 | 0.00 | 1,429,000,000.00 | 0.00 | 0.00 | 300,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20,000,000.00 | 0.00 | 0.00 | 0.00 | -300,000.00 | 0.00 |
NSE: THYROCARE Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1.34 | 0.00 | 142.34 | 4.85 | 4.85 | 70.76 | 47.01 | 166.70 | 147.19 | 100.18 | -2.82 | 4.20 | 2.71 | 67.25 | 70.76 | 479.17 | 4.15 | 5.30 | 5.29 | 0.00 | 0.00 | 70.76 | 70.76 | 0.00 | 70.76 | 1.27 | 69.49 | 69.49 | 26.49 | 95.98 | 0.83 | -0.93 | 0.93 | 0.00 | -2.82 | 1.33 | 4.20 | 2.71 | 92.71 | 312.47 | 87.78 | 47.01 | 47.01 | 65.67 | 32.66 | 33.01 | 4.15 | 405.18 | 166.70 | 571.88 | 571.88 |
| 2023-03-31T00:00:00 | annual | 1.59 | 0.00 | 123.85 | 5.80 | 5.80 | 64.49 | 38.71 | 163.23 | 129.65 | 90.94 | -3.45 | 2.35 | 1.38 | 60.28 | 64.49 | 442.05 | 5.61 | 5.30 | 5.29 | 0.00 | 0.00 | 64.49 | 64.49 | 0.00 | 64.49 | 0.13 | 64.36 | 64.36 | 24.23 | 88.59 | 0.44 | 0.43 | -0.43 | 0.00 | -3.45 | 2.48 | 2.35 | 1.38 | 84.62 | 278.82 | 84.82 | 38.71 | 38.71 | 43.53 | 20.18 | 23.35 | 5.61 | 363.44 | 163.23 | 526.67 | 526.67 |
| 2022-03-31T00:00:00 | annual | 6.06 | 0.00 | 237.22 | 26.74 | 26.74 | 176.14 | 33.87 | 169.69 | 263.96 | 230.09 | -2.50 | 2.37 | 0.71 | 155.46 | 176.14 | 387.00 | 3.00 | 5.30 | 5.29 | 0.00 | 0.00 | 176.14 | 176.14 | 0.00 | 176.14 | 0.00 | 176.14 | 176.14 | 51.58 | 227.72 | 1.80 | 21.52 | -21.52 | 0.00 | -2.50 | 0.84 | 2.37 | 0.71 | 201.86 | 217.31 | 79.81 | 33.87 | 33.87 | 39.50 | 22.12 | 17.38 | 3.00 | 419.17 | 169.69 | 588.86 | 588.86 |
| 2021-03-31T00:00:00 | annual | 2.43 | 0.00 | 174.10 | 9.52 | 9.52 | 113.15 | 30.28 | 163.90 | 183.62 | 153.34 | -0.08 | 0.87 | 0.79 | 106.06 | 113.15 | 353.49 | 0.84 | 5.30 | 5.29 | 0.00 | 0.00 | 113.15 | 113.15 | 0.00 | 113.15 | 0.00 | 113.15 | 113.15 | 39.32 | 152.47 | 2.12 | 5.84 | -5.84 | 0.00 | -0.08 | 0.02 | 0.87 | 0.79 | 141.13 | 189.59 | 63.16 | 30.28 | 30.28 | 37.24 | 23.89 | 13.35 | 0.84 | 330.72 | 163.90 | 494.62 | 494.62 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
15.77
P/E
59.7305
P/B
10.313021
Dividend Yield
1.89%
Market Cap
4,991.52 Cr.
Face Value
91.336
Book Value
91.336
ROE
13.47%
EBITDA Growth
148.99 Cr.
Debt/Equity
3.796
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of thyrocare?
The market capitalization of Thyrocare Technologies Limited is ₹4,992 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Thyrocare Technologies Limited?
The PE and PB ratios of Thyrocare Technologies Limited are Not Available and 10.313021 respectively as of 05 Feb 2025.
What is the 52 Week High of Thyrocare Technologies Limited?
The 52-week high of Thyrocare Technologies Limited is ₹1050.15 as of 05 Feb 2025.
What is the 52 Week Low of Thyrocare Technologies Limited?
The 52-week low of Thyrocare Technologies Limited is ₹554.1 as of 05 Feb 2025.
What are the earnings per share (EPS) for Thyrocare Technologies Limited?
The Earnings Per Share (EPS) of Thyrocare Technologies Limited is ₹15.77 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Thyrocare Technologies Limited?
The Return on Equity (ROE) of Thyrocare Technologies Limited is 13.47% as per the most recent financial year data. Explore more on Fincept.